Page last updated: 2024-10-27

fluorouracil and Pulmonary Veno Occlusive Disease

fluorouracil has been researched along with Pulmonary Veno Occlusive Disease in 1 studies

Fluorouracil: A pyrimidine analog that is an antineoplastic antimetabolite. It interferes with DNA synthesis by blocking the THYMIDYLATE SYNTHETASE conversion of deoxyuridylic acid to thymidylic acid.
5-fluorouracil : A nucleobase analogue that is uracil in which the hydrogen at position 5 is replaced by fluorine. It is an antineoplastic agent which acts as an antimetabolite - following conversion to the active deoxynucleotide, it inhibits DNA synthesis (by blocking the conversion of deoxyuridylic acid to thymidylic acid by the cellular enzyme thymidylate synthetase) and so slows tumour growth.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Savale, L1
Chaumais, MC1
Dorfmuller, P1
Humbert, M1
Montani, D1

Other Studies

1 other study available for fluorouracil and Pulmonary Veno Occlusive Disease

ArticleYear
Lung transplantation for mitomycin-induced pulmonary veno-occlusive disease.
    Presse medicale (Paris, France : 1983), 2017, Volume: 46, Issue:12 Pt 1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Anus Neoplasms; Female; Fluorouracil; Humans; Hypert

2017